Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Ince TA, Sousa AD, Jones MA, J Harrell C, Agoston ES, Krohn M, et al. Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nat Commun. 2015;6:7419.

Young LM, Marzio A, Perez-Duran P, Reid DA, Meredith DN, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13(3):451-459.

Srivatana V, Muthukumar T, Lee JB, Seshan SV, Hartono C. Quiz Page August 2015: Leukemoid Reaction and Acute Kidney Injury Following Kidney Transplantation. Am J Kidney Dis. 2015;66(2):xx-xxiii.

Nguyen GH, Yassin AH, Magro CM. Unusual variants of intravascular malignant hematopoietic neoplasms: a report of 4 cases and review of the literature. Am J Dermatopathol. 2015;37(5):360-7.

Crescenzo R, Inghirami G. Anaplastic lymphoma kinase inhibitors. Curr Opin Pharmacol. 2015;23:39-44.

DeSimone RA, Mitsios JV, Kucine N, Goss CA, Chadburn A, Cushing MM. Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. Transfusion. 2015;55(10):2304.

Linares JF, Duran A, Reina-Campos M, Aza-Blanc P, Campos A, Moscat J, et al. Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade. Cell Rep. 2015;12(8):1339-52.

Ginter PS, Hoda SA, Ozerdem U. Exuberant squamous metaplasia in an intraductal papilloma of breast. Int J Surg Pathol. 2015;23(2):125-6.

Boi M, Gaudio E, Bonetti P, Kwee I, Bernasconi E, Tarantelli C, et al. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs. Clin Cancer Res. 2015;21(7):1628-38.

Niesvizky R, Badros AZ, Costa LJ, Ely SA, Singhal SB, Stadtmauer EA, et al. Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. Leuk Lymphoma. 2015;56(12):3320-8.